Potent Neutralizing Humanized Antibody With Topical Therapeutic Potential Against HPV18-Related Cervical Cancer

Cervical cancer caused by human papillomavirus (HPV) infections is the fourth most common cancer in women worldwide. Current prophylactic HPV vaccines have achieved promising success in preventing HPV infection. However, still 570,000 new cases were reported in 2018. The current primary treatment fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Bilian, Zhu, Linjing, Wei, Hongxia, Shi, Haixia, Zhang, Doudou, Yuan, Huanyun, Luan, Linlin, Zheng, Nan, Xu, Shijie, Nawaz, Waqas, Hong, Ying, Wu, Xilin, Wu, Zhiwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8264373/
https://www.ncbi.nlm.nih.gov/pubmed/34248960
http://dx.doi.org/10.3389/fimmu.2021.678318

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8264373/
https://www.ncbi.nlm.nih.gov/pubmed/34248960
http://dx.doi.org/10.3389/fimmu.2021.678318

Ejemplares similares